SPARTA BIODISCOVERY LIMITED

Company Registration Number:
13952962 (England and Wales)

Unaudited abridged accounts for the year ended 31 December 2025

Period of accounts

Start date: 01 January 2025

End date: 31 December 2025

SPARTA BIODISCOVERY LIMITED

Contents of the Financial Statements

for the Period Ended 31 December 2025

Balance sheet
Notes

SPARTA BIODISCOVERY LIMITED

Balance sheet

As at 31 December 2025


Notes
2025
2024


£
£
Fixed assets
Tangible assets: 3 357,722 167,810
Total fixed assets: 357,722 167,810
Current assets
Stocks: 237,096 833,667
Debtors: 4 407,617 323,818
Cash at bank and in hand: 579,584 539,335
Total current assets: 1,224,297 1,696,820
Creditors: amounts falling due within one year: 5 (271,293) (357,314)
Net current assets (liabilities): 953,004 1,339,506
Total assets less current liabilities: 1,310,726 1,507,316
Total net assets (liabilities): 1,310,726 1,507,316
Capital and reserves
Called up share capital: 18 17
Share premium account: 3,516,112 2,759,439
Profit and loss account: (2,205,404) (1,252,140)
Shareholders funds: 1,310,726 1,507,316

The notes form part of these financial statements

SPARTA BIODISCOVERY LIMITED

Balance sheet statements

For the year ending 31 December 2025 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

The members have agreed to the preparation of abridged accounts for this accounting period in accordance with Section 444(2A).

These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

The directors have chosen to not file a copy of the company’s profit & loss account.

This report was approved by the board of directors on 23 September 2026
and signed on behalf of the board by:

Name: Jelle Penders
Status: Director

The notes form part of these financial statements

SPARTA BIODISCOVERY LIMITED

Notes to the Financial Statements

for the Period Ended 31 December 2025

1. Accounting policies

These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

SPARTA BIODISCOVERY LIMITED

Notes to the Financial Statements

for the Period Ended 31 December 2025

2. Employees

2025 2024
Average number of employees during the period 12 9

SPARTA BIODISCOVERY LIMITED

Notes to the Financial Statements

for the Period Ended 31 December 2025

3. Tangible Assets

Total
Cost £
At 01 January 2025 215,668
Additions 247,147
At 31 December 2025 462,815
Depreciation
At 01 January 2025 47,858
Charge for year 57,235
At 31 December 2025 105,093
Net book value
At 31 December 2025 357,722
At 31 December 2024 167,810

SPARTA BIODISCOVERY LIMITED

Notes to the Financial Statements

for the Period Ended 31 December 2025

4. Debtors

2025 2024
££
Debtors due after more than one year: 0 0

SPARTA BIODISCOVERY LIMITED

Notes to the Financial Statements

for the Period Ended 31 December 2025

5. Creditors: amounts falling due within one year note

Trade Creditors £172,630 (2024: £68,977) Other taxes and social security £19,281 (£17,224) Other creditors £2,981 (£263,530) Accruals and deferred income £76,401 (£7,583) Total £271,293 (£357,314)

SPARTA BIODISCOVERY LIMITED

Notes to the Financial Statements

for the Period Ended 31 December 2025

6. Financial commitments

The total of future minimum lease payments under non-cancellable operating leases are as follows: Expring not later than one year from reporting date £33,662 (2024: £32,470)